Inventor

BERNER BRET

US71 patents

⚠️ This page may combine multiple inventors who share the name “BERNER BRET”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BERNER BRET

DEPOMED INC

Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

Methods of treatment using a gastric retained gabapentin dosage

Optimal polymer mixtures for gastric retentive tablets

Shell-and-core dosage form approaching zero-order drug release

Shell-and-core dosage form approaching zero-order drug release

Shell-and-core dosage form approaching zero-order drug release

Gastric retained gabapentin dosage form

Methods of treatment using a gastric retained gabapentin dosage

Pharmacological inducement of the fed mode for enhanced drug administration to the stomach

Shell-and-core dosage form approaching zero-order drug release

Methods of treatment using a gastric retained gabapentin dosage form

Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract

Gastric retentive gabapentin dosage forms and methods for using same

CYGNUS THERAPEUTIC SYSTEMS

Monitoring of physiological analytes

Device for signal processing for measurement of physiological analytes

Device for monitoring of physiological analytes

Device for monitoring of physiological analytes

Signal processing for measurement of physiological analysis

Monitoring of physiological analytes

Biosensor and methods of use thereof

BERNER BRET

Shell and core dosage form approaching zero-order drug release

Gastric retained gabapentin dosage form

Methods of treatment using a gastric retained gabapentin dosage

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract

Dosage forms that facilitate rapid activation of barley protease zymogen

HERCON LAB

Device for controlled release drug delivery

Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant

Device for controlled release drug delivery

Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant

Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant

CIBA GEIGY CORP

Mixed solvent mutually enhanced transdermal therapeutic system

Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives

Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives

Transdermal administration of zwitterionic drugs

ANIMAS CORP

Signal processing for measurement of physiological analytes

Monitoring of physiological analytes

ANIMAS TECHNOLOGIES LLC

Monitoring a physiological analytes

Biosensor and methods of use thereof

NOVARTIS AG

Temporally controlled drug delivery systems

Mixed solvent mutually enhanced transdermal therapeutic system

SAGE THERAPEUTICS INC

Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid

Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid

TEIKOKU PHARMA USA INC

Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine

Dexmedetomidine transdermal delivery devices and methods for using the same

ALVINE PHARMACEUTICALS INC

Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance

Formulation for oral administration of proteins

(unassigned)

Biosensor, iontophoretic sampling system, and methods of use thereof

CORVUS PHARMACEUTICALS INC

Pharmaceutical formulations